LENZ Total Assets from 2010 to 2024

LENZ Stock

37.30 1.05 2.90%

LENZ Therapeutics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

188.5 M

Current Value

205.7 M

Quarterly Volatility

135.4 M

Credit Downgrade

Yuan Drop

Covid

Check LENZ Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LENZ Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 2.6 M, Interest Expense of 48 K or Other Operating Expenses of 55.6 M, as well as many indicators such as Price To Sales Ratio of 6.57, Dividend Yield of 0.0 or PTB Ratio of 0.58. LENZ financial statements analysis is a perfect complement when working with LENZ Therapeutics Valuation or Volatility modules.

Check out the analysis of LENZ Therapeutics Correlation against competitors.

For more information on how to buy LENZ Stock please use our How to Invest in LENZ Therapeutics guide.

Latest LENZ Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of LENZ Therapeutics over the last few years. Total assets refers to the total amount of LENZ Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in LENZ Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. LENZ Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LENZ Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 188.46 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

LENZ Total Assets Regression Statistics

	Arithmetic Mean	76,043,353
	Geometric Mean	180,171
	Coefficient Of Variation	178.11
	Mean Deviation	108,513,718
	Median	6,000
	Standard Deviation	135,437,167
	Sample Variance	18343.2T
	Range	402M
	R-Value	0.69
	Mean Square Error	10334.8T
	R-Squared	0.48
	Significance	0
	Slope	20,912,518
	Total Sum of Squares	256805.2T

LENZ Total Assets History

	2024	205.7 M
	2023	188.5 M
	2022	321.9 M
	2021	402 M
	2020	22.6 M

Other Fundumenentals of LENZ Therapeutics

Intangibles To Total Assets

LENZ Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Total Liab	Total Current Assets	Short Term Debt	Accounts Payable	Net Invested Capital	Capital Stock	Net Working Capital	Common Stock	Short Term Investments
Total Assets		1.0	-0.85	-0.74	0.44	1.0	-0.83	0.29	-0.64	0.35	0.59	-0.35	-0.35
Total Stockholder Equity	1.0		-0.86	-0.73	0.39	1.0	-0.8	0.27	-0.62	0.36	0.59	-0.35	-0.35
Net Debt	-0.85	-0.86		0.66	-0.18	-0.88	0.72	0.25	0.38	-0.48	-0.38	0.47	0.47
Retained Earnings	-0.74	-0.73	0.66		-0.32	-0.75	0.83	-0.05	0.92	-0.84	-0.9	0.8	0.8
Total Liab	0.44	0.39	-0.18	-0.32		0.42	-0.74	0.52	-0.31	-0.08	0.27	0.08	0.08
Total Current Assets	1.0	1.0	-0.88	-0.75	0.42		-0.83	0.24	-0.62	0.38	0.59	-0.36	-0.36
Short Term Debt	-0.83	-0.8	0.72	0.83	-0.74	-0.83		-0.17	0.68	-0.5	-0.65	0.48	0.48
Accounts Payable	0.29	0.27	0.25	-0.05	0.52	0.24	-0.17		-0.35	-0.36	0.28	0.36	0.36
Net Invested Capital	-0.64	-0.62	0.38	0.92	-0.31	-0.62	0.68	-0.35		-0.71	-0.94	0.7	0.7
Capital Stock	0.35	0.36	-0.48	-0.84	-0.08	0.38	-0.5	-0.36	-0.71		0.79	-0.85	-0.85
Net Working Capital	0.59	0.59	-0.38	-0.9	0.27	0.59	-0.65	0.28	-0.94	0.79		-0.6	-0.6
Common Stock	-0.35	-0.35	0.47	0.8	0.08	-0.36	0.48	0.36	0.7	-0.85	-0.6		1.0
Short Term Investments	-0.35	-0.35	0.47	0.8	0.08	-0.36	0.48	0.36	0.7	-0.85	-0.6	1.0

Click cells to compare fundamentals

About LENZ Therapeutics Financial Statements

LENZ Therapeutics investors use historical fundamental indicators, such as LENZ Therapeutics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LENZ Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

		Last Reported	Projected for Next Year
	Total Assets	188.5 M	205.7 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ESRT	Empire State Realty
C	Citigroup
C	Citigroup

Additional Tools for LENZ Stock Analysis

When running LENZ Therapeutics' price analysis, check to measure LENZ Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LENZ Therapeutics is operating at the current time. Most of LENZ Therapeutics' value examination focuses on studying past and present price action to predict the probability of LENZ Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LENZ Therapeutics' price. Additionally, you may evaluate how the addition of LENZ Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC